Fedha

Hisa unazofuatilia
002773:SHE
Chengdu Kanghong Pharma Grp Co Ltd
CN¥ 19.44
-1.92%
(-0.38) Siku 1
16 Okt, 15:04:09 GMT +8  ·   CNY
Alama zote
AlamaBeiTofautiTofauti ya asilimia
Inatayarisha maarifa maarufu ya 002773...
Fungua
CN¥ 20.34
Juu
CN¥ 20.34
Chini
CN¥ 19.30
Mtaji wa soko
18.61B
Wastani wa kiasi cha mauzo
7.30M
Kiasi cha mauzo ya hisa
6.59M
Gawio
3.60%
Mgawo wa faida wa kila robo mwaka
CN¥ 0.17
Tarehe ya kutojumuisha gawio
9 Jun 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
18.00
Juu kwa wiki 52
CN¥ 36.10
Chini kwa wiki 52
CN¥ 18.62
EPS
CN¥ 1.08
Hisa za wawekezaji
921.33M
Idadi ya wafanyakazi
elfu 4
Fungua
CN¥ 20.34
Juu
CN¥ 20.34
Chini
CN¥ 19.30
Mtaji wa soko
18.61B
Wastani wa kiasi cha mauzo
7.30M
Kiasi cha mauzo ya hisa
6.59M
Gawio
3.60%
Mgawo wa faida wa kila robo mwaka
CN¥ 0.17
Tarehe ya kutojumuisha gawio
9 Jun 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
18.00
Juu kwa wiki 52
CN¥ 36.10
Chini kwa wiki 52
CN¥ 18.62
EPS
CN¥ 1.08
Hisa za wawekezaji
921.33M
Idadi ya wafanyakazi
elfu 4
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Wasifu
Chengdu Kanghong Pharmaceutical Group Co., Ltd. is a publicly traded pharmaceutical company based in the province of Sichuan, China. It was founded in 1996 and researches, develops, manufactures, and distributes medicines for ophthalmic, central nervous, digestive and endocrine systems. The company is listed on the Shenzhen stock exchange with a market capitalization at around $6 billion. As of May 2021, the company had 18 drugs on the market including Lumitin. Additional products include Songling xuemaikang capsules, Keluoxin capsules, Xinluona, Bolexin and Bosiqing, Yitaning, Shugan Jieyu, Danshu, and Yiqing. Kanghong also currently has 13 subsidiaries in China, Israel, and the United States. Wikipedia
Kuhusu Chengdu Kanghong Pharma Grp Co Ltd
Afisa Mkuu Mtendaji (CEO)-
Wafanyakazielfu 4.47
Lilianzishwa3 Okt 1996
Makao makuu-
Sekta-
Tovuticnkh.com
Ripoti za awaliThamani zote katika CNY
Loading Previous Earnings...
Mapato
Mapato halisi
Thamani zote katika CNY
Sep 2025
Des 2025
Mac 2026
Jun 2026
Mapato
1.17B
961.27M
1.05B
1.13B
Gharama ya bidhaa zilizouzwa
103.16M
116.91M
118.65M
132.03M
Gharama ya mapato
103.16M
116.91M
118.65M
132.03M
Gharama za utafiti na maendeleo
119.54M
198.94M
86.77M
138.57M
Jumla ya gharama za utafiti na maendeleo
-
-
-
-
Gharama za uuzaji, za jumla na za usimamizi
595.28M
521.75M
478.88M
554.55M
Gharama ya uendeshaji
697.02M
764.40M
582.81M
717.78M
Jumla ya gharama za uendeshaji
800.18M
881.31M
701.46M
849.80M
Mapato ya uendeshaji
370.02M
79.96M
345.02M
282.88M
Mapato mengine yasiyo ya uendeshaji
-19.53M
19.27M
-1.04M
-1.54M
EBT ikijumuisha vipengee visivyo vya kawaida
355.99M
147.66M
358.51M
301.88M
EBT bila kujumuisha vipengee visivyo vya kawaida
364.66M
135.96M
356.39M
306.28M
Gharama ya kodi ya mapato
56.73M
23.28M
55.31M
50.13M
Kiwango cha kodi kinachotumika
15.94%
15.77%
15.43%
16.61%
Gharama nyingine za uendeshaji
-17.83M
43.89M
16.62M
23.18M
Mapato halisi
303.21M
130.06M
307.48M
257.26M
Kiwango cha faida halisi
25.91%
13.53%
29.38%
22.71%
Mapato kwa kila hisa
-
-
-
-
Mapato ya riba na uwekezaji
14.20M
36.91M
12.63M
24.92M
Gharama ya riba
-
-
-
-
Jumla ya gharama halisi za riba
14.20M
36.91M
12.63M
24.92M
Gharama za kushuka kwa thamani na za kulipa deni
-
-
-
-
Mapato ya kampuni kabla ya riba, kodi, kushuka thamani na kulipa madeni
427.31M
139.05M
404.11M
345.15M
Faida au hasara kutokana na uuzaji wa vipengee
elfu 3.47
elfu -9.78
-
elfu 61.06
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi
Programu za Google